<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2021.757379</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Murine CXCR3<sup>+</sup>CXCR6<sup>+</sup>&#x3b3;&#x3b4;T Cells Reside in the Liver and Provide Protection Against HBV Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yanan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/710129"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guan</surname>
<given-names>Yun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1045302"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Yuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/695301"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1635837"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lu</surname>
<given-names>Nan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1255156"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Cai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/397299"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University</institution>, <addr-line>Jinan</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Jining No. 1 People&#x2019;s Hospital</institution>, <addr-line>Jining</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Biomedical Sciences, College of Life Sciences, Shandong Normal University</institution>, <addr-line>Jinan</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Institute of Diagnostics, School of Medicine, Cheeloo College of Medicine, Shandong University</institution>, <addr-line>Jinan</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Mengji Lu, Essen University Hospital, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Yongyan Chen, University of Science and Technology of China, China; Sivasankaran M. Ponnan, Fred Hutchinson Cancer Research Center, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Cai Zhang, <email xlink:href="mailto:caizhangsd@sdu.edu.cn">caizhangsd@sdu.edu.cn</email>; Nan Lu, <email xlink:href="mailto:lunan@sdu.edu.cn">lunan@sdu.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>757379</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>12</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Wang, Guan, Hu, Li, Lu and Zhang</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Wang, Guan, Hu, Li, Lu and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Gamma delta (&#x3b3;&#x3b4;) T cells play a key role in the innate immune response and serve as the first line of defense against infection and tumors. These cells are defined as tissue-resident lymphocytes in skin, lung, and intestinal mucosa. They are also relatively abundant in the liver; however, little is known about the residency of hepatic &#x3b3;&#x3b4;T cells. By comparing the phenotype of murine &#x3b3;&#x3b4;T cells in liver, spleen, thymus, and small intestine, a CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T-cell subset with tissue-resident characteristics was found in liver tissue from embryos through adults. Liver sinusoidal endothelial cells mediated retention of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells through the interactions between CXCR3 and CXCR6 and their chemokines. During acute HBV infection, CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells produced high levels of IFN-&#x3b3; and adoptive transfer of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells into acute HBV-infected TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice leading to lower HBsAg and HBeAg expression. It is suggested that liver resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells play a protective role during acute HBV infection. Strategies aimed at expanding and activating liver resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells both <italic>in vivo</italic> or <italic>in vitro</italic> have great prospects for use in immunotherapy that specifically targets acute HBV infection.</p>
</abstract>
<kwd-group>
<kwd>liver</kwd>
<kwd>&#x3b3;&#x3b4;T cells</kwd>
<kwd>residency</kwd>
<kwd>liver-resident &#x3b3;&#x3b4;T cells</kwd>
<kwd>chemotaxis</kwd>
<kwd>HBV infection</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="70"/>
<page-count count="13"/>
<word-count count="5597"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The liver is not only involved in regulating metabolism but also has important immunological characteristics (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Liver tissue is enriched with innate immune cells that can effectively and quickly defend against invading microorganisms and tumor transformation (<xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>). Lymphocytes are classically viewed as continuously circulating in peripheral organs; however, recent studies demonstrate the existence of tissue-resident lymphocytes in the skin, lung, and intestinal mucosa and other peripheral organs, where they exert protective immunity to infection and malignancy (<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B9">9</xref>). Notably, the liver contains multiple resident lymphocytes including memory CD8<sup>+</sup> T (T<sub>RM</sub>) cells, invariant natural killer T (iNKT) cells, mucosal-associated invariant T (MAIT) cells, and natural killer (NK) cells (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Liver-resident lymphocytes have a similar distribution, phenotype, and method of transcriptional regulation and function (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>).</p>
<p>&#x3b3;&#x3b4;T cells are a unique subset of innate-like T lymphocytes with diverse structural and functional heterogeneity. Unlike &#x3b1;&#x3b2;T cells, &#x3b3;&#x3b4;T cells recognize antigens independent of MHC restriction and do not require antigen processing and presentation (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). Murine &#x3b3;&#x3b4;T cells constitute only a small proportion of lymphocytes in peripheral organs&#x2014;such as spleen and lymph nodes&#x2014;but are abundant in the liver, accounting for 3%&#x2013;5% of all intrahepatic lymphocytes. In an acute HBV infection model, the number of hepatic &#x3b3;&#x3b4;T cells significantly increases and exhibits elevated expression of the activation marker, CD69 (<xref ref-type="bibr" rid="B18">18</xref>). However, the role of &#x3b3;&#x3b4;T cells during the early stages of acute HBV infection is not well defined. &#x3b3;&#x3b4;T cells are present in high numbers in epithelial and mucosal barriers and several &#x3b3;&#x3b4;T-cell subsets naturally establish residency at barrier sites, as illustrated by the presence of V&#x3b3;5<sup>+</sup> and V&#x3b3;3V&#x3b4;1<sup>+</sup> T-cell subsets in the intestinal epithelium and epidermis, respectively (<xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B22">22</xref>). Tian&#x2019;s group reported a liver-resident &#x3b3;&#x3b4;T population maintained by gut commensal microbes through CD1d/lipid antigens. This liver-resident &#x3b3;&#x3b4;T-cell population predominantly produced IL-17A and accelerated the progression of nonalcoholic fatty liver disease (<xref ref-type="bibr" rid="B23">23</xref>). However, there is a limited understanding of the resident characteristics of &#x3b3;&#x3b4;T cells in the hepatic immune microenvironment. A deeper and more comprehensive understanding of liver-resident &#x3b3;&#x3b4;T cells will inform the development of novel treatments for diverse liver diseases.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Animals</title>
<p>Five to 8-week-old male C57BL/6J, BALB/c, and nude mice were purchased from Beijing Hua Fukang Bioscience Co., Ltd. (Beijing, China). TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice were a gift from Dr. Zhinan Yin (Nankai University). CD45.1<sup>+</sup> mice were a gift from Dr. Zhigang Tian (University of Science and Technology of China). All mice were housed in a specific pathogen-free facility under ethical conditions. Experiments were performed with age- and sex-matched animals according to the guidelines for experimental animals from Shandong University and were approved by the Committee on the Ethics of Animal Experiments of Shandong University (Jinan, China) (2017-D023).</p>
</sec>
<sec id="s2_2">
<title>Acute HBV Infection Model</title>
<p>The pAAV plasmid and the pAAV-HBV1.2 plasmid containing the full-length HBV DNA were kindly provided by Dr. Peijer Chen (National Taiwan University College of Medicine, Taipei, China). An acute HBV infection model was established by hydrodynamic injection of 20 &#x3bc;g pAAV-HBV1.2 plasmid in 1&#xd7; phosphate buffer solution (PBS) equivalent to 10% of the mouse body weight by way of the tail veil into wild-type (WT) C57BL/6J and TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice (<xref ref-type="bibr" rid="B24">24</xref>).</p>
</sec>
<sec id="s2_3">
<title>Parabiosis</title>
<p>Parabiosis was established as described previously (<xref ref-type="bibr" rid="B25">25</xref>). In brief, 5- to 6-week-old male CD45.1<sup>+</sup> and CD45.2<sup>+</sup> C57BL/6J mice were matched for body weight and anaesthetized prior to surgery. An incision along the lateral aspect was performed from 0.5 cm above the elbow to 0.5 cm below the knee joint, and the skin was gently detached from the subcutaneous fascia. The knee joints and skins of the paired mice were attached from the elbow to the knee with nonabsorbable silk. Neomycin was added to the drinking water for 7 days. Two weeks after parabiosis, two mice shared the blood circulation.</p>
</sec>
<sec id="s2_4">
<title>Cell Isolation</title>
<p>Mice were sacrificed, and the bone marrow (BM), inguinal lymph node (iLN), spleen, liver, thymus, intestine, and skin were collected. MNCs from each organ were separated and mononuclear cells (MNCs) were collected. In brief, iLN and thymus were passed through a 200-gauge steel mesh and centrifuged at 400&#xd7;<italic>g</italic> for 5 min in 1 &#xd7; PBS. Spleens were first passed through a 200-gauge steel mesh, lysed with red blood cell (RBC) lysis buffer and washed with 1 &#xd7; PBS. Bone marrows were washed by syringe, and MNCs were harvested after RBC lysis and washing. Livers were passed through a 200-gauge steel mesh, and the cell pellets were collected. MNCs were isolated by gradient centrifugation with 40% Percoll at 800&#xd7;<italic>g</italic> for 25 min and harvested after RBC lysis and washing. Skins were excised and minced into small pieces, then digested with 0.04% collagenase I (Gibco, Carlsbad, CA, USA) for 2 h at 37&#xb0;C. The large pieces were removed by filtration, and the MNCs were obtained by gradient centrifugation with 40% and 70% Percoll. IELs were isolated from the small intestine as previously described (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Peyer&#x2019;s patches (PP) were surgically removed from the intestines and excised into small pieces. The specimens were then digested with prewarmed IEL digestive juice and incubated with stirring for 40 min at 37&#xb0;C and passed over two nylon wool columns to remove undigested tissue debris. IELs were isolated by gradient centrifugation with 40% and 70% Percoll (GE Healthcare, Uppsala, Sweden).</p>
<p>The mice were anesthetized prior to a laparotomy to obtain the LSECs. The liver was perfused with EGTA/HBSS solution through the portal vein. The inferior vena cava was rapidly cut after the liver turned completely pale. Next, the liver was perfused with 37&#xb0;C prewarmed Collagenase IV (Gibco) solution for 5 min, excised, and digested in collagenase solution for 15 min in a 37&#xb0;C incubator. LSECs were obtained by gradient centrifugation with 25% and 50% Percoll. The cellular precipitate was resuspended in 1 ml DMEM+10% FBS medium and seeded into 24-well plates at a density of 1 &#xd7; 10<sup>5</sup> cells/well. After 4 h, the supernatant was gently removed and replaced with 500 &#x3bc;l fresh DMEM medium.</p>
</sec>
<sec id="s2_5">
<title>Flow Cytometry</title>
<p>MNCs in a single-cell suspension were blocked with anti-CD16/32 (eBioscience, San Diego, CA, USA) and stained with a cocktail of antibodies specific for different cell types for 30 min at 4&#xb0;C. The foxp3 staining kit (eBioscience) was used to stain the nucleus transcription factor. To detect expression of IL-17A and IFN-&#x3b3;, the cells were stimulated with phorbol 12-myristate 13-acetate (PMA, 30 ng/ml, Sigma-Aldrich Co., St. Louis, MO, USA) and ionomycin (1 &#x3bc;g/ml, Sigma-Aldrich) for 4 h and treated with monensin (1 &#x3bc;g/ml, Sigma-Aldrich) and brefeldin A (BFA, 1 &#x3bc;g/ml, Biolegend, San Diego, CA, USA) after 1 h of stimulation. After surface staining, cells were fixed, permeabilized, and stained with the indicated intracellular antibodies. Flow cytometry was performed using a fluorescence-activated cell sorter (FACS) Aria III (BD Biosciences, San Jose, CA, USA), and data were analyzed with FlowJo software (TreeStar Inc., Ashland, OR, USA). At least 3 &#xd7; 10<sup>5</sup> total events were needed for the FACS analysis. Data are presented in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>.</p>
</sec>
<sec id="s2_6">
<title>Cell Sorting and Adoptive Transfer</title>
<p>Hepatic MNCs were stained with anti-CD3e, anti-TCR&#x3b3;/&#x3b4;, anti-CXCR3, and anti-CXCR6 antibodies to sort CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells using a FACS Aria III (BD Biosciences). The purity of the sorted cell populations was &gt;95%. Approximately 50,000 purified CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells in 200 &#x3bc;l 1 &#xd7; PBS were intravenously injected into sublethally irradiated TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice (6.5 Gy given 1 day before adoptive transfer). An acute HBV infection model was established in WT, TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup>, and TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice after adoptive transfer of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells.</p>
</sec>
<sec id="s2_7">
<title>RNA Isolation and Real-Time PCR</title>
<p>Total &#x3b3;&#x3b4;T-cell RNA from the indicated tissues was extracted using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer&#x2019;s instructions. The RNA concentration was quantified using Nanodrop 2000 (Thermo Fisher, Waltham, MA, USA). cDNA was generated using a FastQuant RT Kit (Tiangen Biotech Co. Ltd., Beijing, China) and real-time polymerase chain reaction was performed using a SYBR Green SuperMix (Roche, Basel, Switzerland) on a LightCycler 480 platform (Roche). Relative mRNA levels were normalized to &#x3b2;-actin mRNA levels. The primers are described in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S2</bold>
</xref>.</p>
</sec>
<sec id="s2_8">
<title>Transwell Assay</title>
<p>Hepatic MNCs were seeded at 5 &#xd7; 10<sup>5</sup> in 100 &#x3bc;l serum-free RPMI-1640 media in the above inserts with a pore size of 0.4 &#x3bc;m. The lower chamber contained 500 &#x3bc;l DMEM medium with untreated LSECs or LSECs incubated with neutralizing chemokine-targeting antibodies at 37&#xb0;C for 2 h. After a 2-h incubation, absolute numbers of the migrated cells were detected by FACSAria III.</p>
</sec>
<sec id="s2_9">
<title>Chemokine Detection by ELISA</title>
<p>The LSECs were inoculated into 24-well plates (1 &#xd7; 10<sup>5</sup> cells/well). After culturing for 4 h, the supernatant was absorbed, washed three times with 1 &#xd7; PBS, and replaced with fresh DMEM medium (500 &#x3bc;l). Cell culture supernatants were collected at 24 h. CXCL9, CXCL10, CXCL11, and CXCL16 chemokine levels were detected in the LSEC culture supernatants by ELISA (PeproTech, East Windsor, New Jersey, USA) according to the manufacturers&#x2019; instructions.</p>
</sec>
<sec id="s2_10">
<title>Serum HBV Ag Assays</title>
<p>Serum hepatitis B surface Ag (HBsAg) and hepatitis BeAg (HBeAg) from mice with acute HBV infection were assayed using the HBsAg and HBeAg detection kits (Autobio, Zhengzhou, China) according to the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="s2_11">
<title>HBV DNA Detection</title>
<p>Serum HBV DNA copies were extracted from 50 &#x3bc;l serum and detected by quantitative PCR using a diagnostic kit for HBV DNA (Da An Gene, Guangzhou, China) according to the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="s2_12">
<title>Statistical Analysis</title>
<p>The data were analyzed using GraphPad Prism 7 software (GraphPad Software Inc., San Diego, CA, USA). Data are presented as the mean &#xb1; standard error of the mean (SEM). Differences between more than two groups were statistically analyzed by one-way analysis of variance (one-way ANOVA). A two-way ANOVA test was used to determine differences in HBsAg, HBeAg, and HBV DNA tests. A <italic>p</italic>-value &lt;0.05 was considered statistically significant (<sup>*</sup>
<italic>p</italic> &lt; 0.05; <sup>**</sup>
<italic>p</italic> &lt; 0.01; <sup>***</sup>
<italic>p</italic> &lt; 0.001).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T Cells Only Exist in Liver</title>
<p>IELs and skin are rich in &#x3b3;&#x3b4;T cells, where they regulate inflammation, pathogen invasion, and tumor surveillance (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). In this study, the liver also had a higher proportion of &#x3b3;&#x3b4;T cells than other immune organs and tissues, including the BM, inguinal LN, spleen, and thymus (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref> and <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, B</bold>
</xref>). This finding correlates with results from a recent study (<xref ref-type="bibr" rid="B23">23</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Liver contains abundant &#x3b3;&#x3b4;T cells that exhibit a unique phenotype. <bold>(A)</bold> Representative FACS plots of &#x3b3;&#x3b4;T cells (CD3<sup>+</sup>TCR&#x3b3;&#x3b4;<sup>+</sup>) in BM, IEL, iLN, liver, skin, spleen, and thymus of C57BL/6J mice. <bold>(B)</bold> Statistical analysis of &#x3b3;&#x3b4;T-cell percentages in the indicated organs. <bold>(C&#x2013;E)</bold> Representative FACS plots (left) and percentage (right) of &#x3b3;&#x3b4;T surface markers on cells in indicated organs. Each dot represents a mouse. Data are shown as mean &#xb1; SEM. (<sup>*</sup>
<italic>p</italic> &lt; 0.05; <sup>**</sup>
<italic>p</italic> &lt; 0.01; <sup>***</sup>
<italic>p</italic> &lt; 0.001. One-way ANOVA with <italic>post-hoc</italic> test). BM, bone marrow; IEL, intraepithelial lymphocyte; iLN, inguinal lymph node; NS, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-757379-g001.tif"/>
</fig>
<p>This study also assessed the phenotype of &#x3b3;&#x3b4;T cells in liver, first by analyzing molecules associated with &#x3b3;&#x3b4;T-cell-induced cytokine production. Hepatic &#x3b3;&#x3b4;T cells expressed low levels of CD27, which is a fate determinant of &#x3b3;&#x3b4;T cells to express IFN-&#x3b3; but not IL-17A. The expression was similar in &#x3b3;&#x3b4;T cells from the IEL but significantly lower than &#x3b3;&#x3b4;T cells from the spleen and thymus (<xref ref-type="bibr" rid="B30">30</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). Hepatic &#x3b3;&#x3b4;T cells also expressed higher levels of IL-2 receptor beta CD122, which is expressed on IFN-&#x3b3;<sup>+</sup> &#x3b3;&#x3b4;T cells, compared with &#x3b3;&#x3b4;T cells from other immune organs and tissues (<xref ref-type="bibr" rid="B31">31</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). Hepatic &#x3b3;&#x3b4;T cells exhibited higher NKG2D expression, indicating that these cells may be involved in immune defense and tissue protection in the liver (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). &#x3b3;&#x3b4;T cells induce effector&#x2212;target cell apoptosis through the Fas&#x2013;FasL pathway (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Hepatic &#x3b3;&#x3b4;T cells have a higher expression of Fas (CD95) than intestinal epithelial &#x3b3;&#x3b4;T cells but lower expression than thymic &#x3b3;&#x3b4;T cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Importantly, hepatic &#x3b3;&#x3b4;T cells expressed a high level of the adhesion and retention molecule, CD44, and a low level of the lymph node homing molecule, CD62L (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). Overall, these data indicate that hepatic &#x3b3;&#x3b4;T cells exhibited a unique phenotype that was distinct from &#x3b3;&#x3b4;T cells found in other organs.</p>
<p>Chemokines and chemokine receptors regulate the trafficking and accumulation of lymphocytes in homeostasis and disease. The mRNA level of chemokine receptors in &#x3b3;&#x3b4;T cells was measured in multiple organs. As shown in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>, CXCR3, CXCR6, and CCR2 mRNA levels were higher in hepatic &#x3b3;&#x3b4;T cells than in other tissues and organs. Hepatic &#x3b3;&#x3b4;T cells from nude mice still retained high CXCR3 and CXCR6 expression (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>), indicating that thymus deficiency did not impact expression. CXCR3 and CXCR6 expression was further examined by flow cytometry. Results showed that hepatic &#x3b3;&#x3b4;T cells expressed higher levels of CXCR3 and CXCR6 than those from spleen, IEL, and thymus in C57BL/6J mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref> and <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). Furthermore, the CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T-cell subset was found in liver but not in the spleen, IEL, or thymus (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). These data indicate that hepatic &#x3b3;&#x3b4;T cells exhibited a unique phenotype and the CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T subset specifically exists in liver.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Liver contains a specific CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T subset. <bold>(A)</bold> CXCR3, CXCR6, CCR2, and CCR6 mRNA expression in &#x3b3;&#x3b4;T cells from indicated organs of C57BL/6J mice. <bold>(B)</bold> CXCR3, CXCR6, and CCR2 mRNA expression in &#x3b3;&#x3b4;T cells from IEL, liver, spleen, and iLN of BALB/c and nude mice. <bold>(C)</bold> Representative FACS plots and percentage of &#x3b3;&#x3b4;T cells expressing CXCR6 or CXCR3 in liver, spleen, IELs, and thymus of C57BL/6J mice. Each dot represents a mouse. Data are shown as mean &#xb1; SEM. (<sup>***</sup>
<italic>p</italic> &lt; 0.001. One-way ANOVA with <italic>post-hoc</italic> test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-757379-g002.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T Cells Have Tissue-Resident Characteristics and Specifically Reside in Liver</title>
<p>Tissue-resident lymphocytes often express CD103, CD69, CD44, and CD49a, which mediate adhesion and retention, and lack the lymphoid homing markers, CD62L and CCR7 (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B34">34</xref>). In this study, hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells expressed high levels of CD69, CD103, CD44, and CD49a (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>) and low levels of CD62L and CCR7 (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S3</bold>
</xref>). These cells also expressed a high level of the transcription factor, PLZF, which is important for innate tissue-resident lymphocytes like iNKT cells and MAIT cells (<xref ref-type="bibr" rid="B35">35</xref>), and a low level of BlIMP1, which correlates with diverse tissue-resident lymphocyte populations such as T<sub>RM</sub> and NKT cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). These data indicate that hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells have tissue-resident characteristics.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells have tissue-resident characteristics and specifically reside in liver. <bold>(A&#x2013;C)</bold> FACS analysis of CD69, CD103, CD44, and CD49a <bold>(A)</bold>, CD62L and CCR7 <bold>(B)</bold>, and PLZF and Blimp1 <bold>(C)</bold> expression on hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells from C57BL/6J mouse livers. <bold>(D)</bold> Parabiotic joining of CD45.1 and congenic CD45.2 mice led to the development of a shared circulatory system 2 weeks after surgery. <bold>(E)</bold> The percentages of CD45.1<sup>+</sup> and CD45.2<sup>+</sup> cells in peripheral blood lymphocytes (PBLs) in parabiosis models. <bold>(F)</bold> Gating strategy of CD45.1<sup>+</sup> or CD45.2<sup>+</sup> expression on hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells. <bold>(G)</bold> The host origin (CD45.1<sup>+</sup> or CD45.2<sup>+</sup>) of hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells was identified by FACS analysis in each mouse in the CD45.1/CD45.2 parabiotic mouse pairs at 14 days postsurgery. <bold>(H)</bold> The percentage of CD45.1<sup>+</sup> or CD45.2<sup>+</sup> conventional T cells (CD3<sup>+</sup>TCR&#x3b3;&#x3b4;<sup>-</sup>NK1.1<sup>&#x2212;</sup>), &#x3b3;&#x3b4;T cells (CD3<sup>+</sup>TCR&#x3b3;&#x3b4;<sup>+</sup>), and CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells from the liver of CD45.1/CD45.2 parabiotic B6 mouse.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-757379-g003.tif"/>
</fig>
<p>To further confirm whether these cells specifically reside in liver, CD45.1<sup>+</sup> and CD45.2<sup>+</sup> mice were surgically joined by parabiosis (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>). After 2 weeks, the percentages of CD45.1<sup>+</sup> or CD45.2<sup>+</sup> cells in peripheral blood lymphocytes (PBLs) were equivalent, indicating that the parabiosis models were successfully established (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). The redistribution of &#x3b3;&#x3b4;T cells in each mouse in the CD45.1/CD45.2 parabiotic mouse pairs was assessed (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>). While conventional T cells were mutually exchanged, hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells from the CD45.1<sup>+</sup> parabiont mice were almost entirely CD45.1<sup>+</sup>, with very few CD45.2<sup>+</sup>, while CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells from the CD45.2<sup>+</sup> parabiont mice were primarily CD45.2<sup>+</sup> (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3G, H</bold>
</xref>). These data suggest that hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells were seldom exchanged between CD45.1<sup>+</sup> and CD45.2<sup>+</sup> parabiont mice. In addition, 70%&#x2013;80% CXCR3<sup>+</sup>CXCR6<sup>&#x2212;</sup> &#x3b3;&#x3b4;T cells and CXCR3<sup>&#x2212;</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells were CD45.1<sup>+</sup> in CD45.1<sup>+</sup> parabiont mice, whereas the reverse was observed in CD45.2<sup>+</sup> parabiont mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S4</bold>
</xref>). In summary, the parabiosis assay indicated that CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells were predominantly retained in the liver, while CXCR3<sup>+</sup>CXCR6<sup>&#x2212;</sup> &#x3b3;&#x3b4;T cells and CXCR3<sup>&#x2212;</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells have less liver-resident features.</p>
</sec>
<sec id="s3_3">
<title>Liver-Resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T Cells Exist in Liver From Embryo to Adulthood</title>
<p>In general, &#x3b3;&#x3b4;T cells are exported from the thymus at defined periods of fetal and neonatal development, and then migrate to and populate different peripheral tissues in adult animals (<xref ref-type="bibr" rid="B36">36</xref>). However, intestinal &#x3b3;&#x3b4;T cells can also develop in intestinal crypts and reside in the gut (<xref ref-type="bibr" rid="B37">37</xref>). To explore whether the existence of hepatic &#x3b3;&#x3b4;T cells was dependent on the thymus, the proportion of &#x3b3;&#x3b4;T cells in athymic nude and WT BALB/c mice were assessed. The proportion of intestinal &#x3b3;&#x3b4;T cells in nude mice was nearly identical to the proportion of intestinal &#x3b3;&#x3b4;T cells in WT BALB/c mice. Importantly, the liver still contained &#x3b3;&#x3b4;T cells in athymic nude mice despite the lack of &#x3b3;&#x3b4;T cells in the spleen (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures S5A, B</bold>
</xref>). These data suggest that some hepatic &#x3b3;&#x3b4;T cells are not dependent on the thymus. Assessment of &#x3b3;&#x3b4;T cells during different stages of growth showed that they are found in liver and thymus from embryo to adulthood. As the mice grew, the percentage of &#x3b3;&#x3b4;T cells decreased in the thymus and increased in the liver (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S6</bold>
</xref>). More importantly, CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells were present in the liver from embryo to adulthood and the proportion increased as the mice aged; however, they were absent in the thymus during particular stages of growth (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells exist in liver and express tissue-resident markers from embryo to adulthood. <bold>(A)</bold> FACS analysis of &#x3b3;&#x3b4;T cells in thymus (top) and liver (bottom) at different developmental stages of C57BL/6J mice. <bold>(B)</bold> FACS analysis of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells in the thymus and liver at the different developmental stages of C57BL/6J mice. <bold>(C, D)</bold> FACS analysis of T-bet and ROR&#x3b3;t <bold>(C)</bold> and CD103, CD69, CD62L, and PLZF expression <bold>(D)</bold> in hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells at the indicated ages over time.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-757379-g004.tif"/>
</fig>
<p>CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells expressed high levels of the IFN-&#x3b3;-associated transcriptional factor, T-bet, from embryo to adulthood, while rarely expressing the IL-17A-associated transcriptional factor, ROR&#x3b3;t (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). In addition, hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells expressed a high level of tissue-resident-associated molecules like CD103 and CD69 and the transcription factor, PLZF, but rarely expressed CD62L during development (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref> and <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S7</bold>
</xref>).</p>
<p>In summary, these data collectively indicate that CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells are retained in liver from embryo to adulthood and have tissue-resident characteristics during mouse development.</p>
</sec>
<sec id="s3_4">
<title>Liver Sinusoidal Endothelium Cells Mediate Retention of Liver-Resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T Cells</title>
<p>LSECs secrete a variety of chemokines that promote the recruitment of immune cells (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Results from the present study showed that the liver-resident &#x3b3;&#x3b4;T-cell subset specifically expressed the chemokine receptors, CXCR3 and CXCR6. Thus, we hypothesized that chemotaxis may play an important role in the recruitment and retention of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells in the liver. LSECs were isolated and chemokines, including the ligands of CXCR3 (CXCL9, CXCL10, CXCL11) and the ligand of CXCR6 (CXCL16), were measured in the culture supernatants. LSECs produced high levels of CXCL9, CXCL11, and CXCL16 (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>). To further demonstrate the recruitment function of LSECs, a transwell assay was performed to test the chemotactic ability of chemokines secreted by LSECs on CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). When the lower chamber contained untreated LSECs, CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells were recruited from the above inserts. Chemotaxis was significantly reduced when CXCL9 and CXCL11 were neutralized, indicating that the chemokines, CXCL9 and CXCL11, play important roles in the retention of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). When CXCL16 was neutralized, the level of chemotaxis between the LSECs and CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells was also weakened (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). These findings indicate that the chemokines, CXCL9, CXCL11, and CXCL16, are all required for the retention of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells. Taken together, these results indicate that LSECs play an important role in retaining liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells through the interaction between the chemokine receptors, CXCR3 and CXCR6, and their ligands.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>LSECs promote the recruitment of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells to the liver. <bold>(A)</bold> Freshly isolated LSECs (1 &#xd7; 10<sup>5</sup> per well) were seeded into 24-well plates and incubated at 37&#xb0;C. The culture supernatant of each well was collected at 24 h and CXCL9, CXCL10, CXCL11, and CXCL16 levels in the culture supernatant were detected by ELISA. <bold>(B)</bold> Transwell was performed to test the chemotactic effect of LSECs to CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells. The inserts were seeded with 5 &#xd7; 10<sup>5</sup> liver mononuclear cells in 100 &#xb5;l serum-free RPMI-1640 media. The lower chamber contained 500 &#xb5;l DMEM medium with untreated LSECs or LSECs incubated with neutralizing antibodies specific for indicated chemokines at 37&#xb0;C for 2 h. <bold>(C)</bold> FACS analysis (left) and absolute numbers (right) of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells in the lower chamber migrated from the upper insert after a 2-h incubation. Data are shown as mean &#xb1; SEM. (<sup>**</sup>
<italic>p</italic> &lt; 0.01; <sup>***</sup>
<italic>p</italic> &lt; 0.001. One-way ANOVA with <italic>post-hoc</italic> test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-757379-g005.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Liver-Resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T Cells Play a Protective Role During Acute HBV Infection</title>
<p>Liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells produced high levels of IFN-&#x3b3; and expressed a high level of the IFN-&#x3b3; transcription factor, T-bet (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S8</bold>
</xref> and <xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>). However, these cells produced very little IL-17A and expressed low levels of the IL-17A transcription factor, ROR&#x3b3;t (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>). The production of IFN-&#x3b3; indicated that liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells may be involved in protective immunity against viruses and intracellular pathogens. In an acute HBV infection model, the proportion and absolute numbers of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells increased on day 7 and returned to normal levels as the infection progresses (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). The expression of Ki67 was measured at different time points. On the third day after infection, CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells showed significantly higher expression of Ki67, indicating that the proliferative capacity of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells was enhanced postinfection (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>). Notably, IFN-&#x3b3; levels increased after 7 days postinfection (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>). These results indicate that liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells proliferate during acute HBV infection and IFN-&#x3b3; from these cells may be involved in eliminating HBV. IL-17A secretion increased at the early stage of infection, and decreased after 10 days, and was then maintained at a low level (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells contribute to the clearance of HBV. <bold>(A)</bold> IFN-&#x3b3; and IL-17A expression on PMA/ionomycin-stimulated CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells in the liver of C57BL/6J mice. <bold>(B)</bold> T-bet and ROR&#x3b3;t expression in hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells. <bold>(C)</bold> An acute HBV infection model was established by hydrodynamic injection of pAAV-HBV1.2 plasmid into the tail veil. The absolute numbers (left) and percentages (right) of liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells after acute HBV infection at the indicated time points. <bold>(D)</bold> FACS analysis (left) and statistical analysis (right) of Ki67 on CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells after acute HBV infection at the indicated time points. <bold>(E)</bold> FACS analysis (left) and statistical analysis (right) of IFN-&#x3b3; (top) and IL-17 (bottom) secreted by PMA/ionomycin-stimulated CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells after acute HBV infection at the indicated time points. <bold>(E)</bold> HBsAg, HBeAg, and HBV DNA detection in serum at the indicated time points of an HBV acute infection model in WT, TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup>, and TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice after adoptive transfer of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells. Data are shown as mean &#xb1; SEM. [<sup>*</sup>
<italic>p</italic> &lt; 0.05; <sup>**</sup>
<italic>p</italic> &lt; 0.01; <sup>***</sup>
<italic>p</italic> &lt; 0.001. One-way ANOVA with <italic>post-hoc</italic> test <bold>(C&#x2013;E)</bold>, two-way ANOVA test <bold>(F)</bold>]. NS, not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-757379-g006.tif"/>
</fig>
<p>To further investigate the role of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells during HBV infection, the acute HBV infection model was established in WT, TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice, and TCR&#x3b4;<sup>-/-</sup> mice that were adoptively transferred with CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells. HBsAg, HBeAg, and HBV DNA levels were measured in serum at different time points. TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice that had received CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells exhibited markedly lower serum HBsAg, HBeAg, and HBV DNA levels than TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice that did not receive CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6F</bold>
</xref>). These data suggest that liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells may be involved in the clearance of HBV. Interestingly, TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice had lower serum HBsAg, HBeAg, and HBV DNA than WT mice, suggesting that other subsets of &#x3b3;&#x3b4;T cells may have different or even opposing effects during acute HBV infection. The roles of other subsets of &#x3b3;&#x3b4;T cells in acute HBV infection deserved further research.</p>
<p>These findings demonstrate that liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells exert a protective role during acute HBV infection through production of IFN-&#x3b3;.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>In the present study, a unique &#x3b3;&#x3b4;T-cell subset characterized by CXCR3<sup>+</sup>CXCR6<sup>+</sup> expression was specifically found to reside in murine liver. Moreover, these cells existed from embryo to adult and exhibited tissue-resident characteristics. LSECs promoted the recruitment and retention of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells by secreting CXCL9, CXCL11, and CXCL16. Importantly, liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells secreted high levels of IFN-&#x3b3; and provided protection against acute HBV infection.</p>
<p>Tissue-resident lymphocytes share similar phenotypes, functional properties, and transcriptional regulation (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B34">34</xref>). CXCR3 and CXCR6 are present in liver-resident NK cells and CD8<sup>+</sup> T cells (<xref ref-type="bibr" rid="B40">40</xref>&#x2013;<xref ref-type="bibr" rid="B42">42</xref>). The engagement of chemokines and chemokine receptors is required for lymphocyte trafficking and retention in the liver. CXCR3 and its ligands mediate T-cell and TRAIL<sup>+</sup> liver-resident NK cell chemotaxis toward the liver (<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B44">44</xref>). Liver-resident NK cells, NKT cells, and CD8<sup>+</sup> T cells are selectively retained in liver in response to the chemotactic stimuli provided through the CXCR6 and CXCL16 interaction (<xref ref-type="bibr" rid="B45">45</xref>&#x2013;<xref ref-type="bibr" rid="B47">47</xref>). Results from the present study provide the first evidence that CXCR3, CXCR6, and their ligands are critical for the accumulation and residency of &#x3b3;&#x3b4;T cells. Hepatic CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells express PLZF, which is involved in a transcriptional network that promotes liver residency of human NK cells (<xref ref-type="bibr" rid="B48">48</xref>). A parabiosis model, one of the most common methods for assessing tissue residency (<xref ref-type="bibr" rid="B25">25</xref>), was used to further verify that CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells specifically reside in the liver.</p>
<p>Similar to the intestine, the liver still contained &#x3b3;&#x3b4;T cells in athymic nude mice (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S5</bold>
</xref>), indicating that hepatic &#x3b3;&#x3b4;T cells do not dependent on the thymus. Furthermore, CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells were not present in the thymus at all stages of growth, these cells were present in the liver from embryo to adulthood and the percentage increased as mice aged (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). These findings indicated that liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells may have a unique development pathway. While the thymus provides an inductive environment for the development of T cells from hematopoietic progenitor cells, prior studies have shown that &#x3b3;&#x3b4;T cells can develop extrathymically. Intestinal &#x3b3;&#x3b4;T cells, for example, can develop in intestinal crypts and reside in the gut (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). In addition, the adult liver contains hematopoietic stem and progenitor cells (HSPCs) and is believed to be an extramedullary hematopoietic organ (<xref ref-type="bibr" rid="B51">51</xref>&#x2013;<xref ref-type="bibr" rid="B53">53</xref>). Hepatic heterogeneous Lin<sup>&#x2212;</sup>Sca-1<sup>+</sup>c-Kit<sup>+</sup> (LSK, contains hematopoietic stem cells and multipotent progenitors) cells can differentiate into both myeloid cells and lymphocytes, including &#x3b3;&#x3b4;T cells, and type 1 innate lymphoid cells (ILC1s) (<xref ref-type="bibr" rid="B54">54</xref>&#x2013;<xref ref-type="bibr" rid="B56">56</xref>). Our recent findings showed that liver hematopoietic progenitor Lin<sup>&#x2212;</sup>Sca-1<sup>+</sup>Mac-1<sup>+</sup> (LSM) cells can differentiate into &#x3b3;&#x3b4;T-cell precursor (pre-&#x3b3;&#x3b4;T) cells and functionally mature IFN-&#x3b3;<sup>+</sup> &#x3b3;&#x3b4;T cells but not IL-17a<sup>+</sup> &#x3b3;&#x3b4;T cells in a thymus-independent manner. This research suggests that &#x3b3;&#x3b4;T cells are involved in a distinct developmental pathway that is independent of the thymus (<xref ref-type="bibr" rid="B57">57</xref>). More evidence is required to better understand how liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells develop.</p>
<p>&#x3b3;&#x3b4;T cells can establish long-lived memory and resident populations in response to local inflammation or pathogen invasion and exert long-term protective roles (<xref ref-type="bibr" rid="B19">19</xref>&#x2013;<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Circulating &#x3b3;&#x3b4;T cells participate in lymphoid stress surveillance during HBV infection with differential activation and differentiation (<xref ref-type="bibr" rid="B59">59</xref>). However, the role of liver-resident &#x3b3;&#x3b4;T cells during acute HBV infection remains unknown. In the current study, CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells produced more IFN-&#x3b3; and were associated with reduced disease severity after adoptive transfer into HBV-infected TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). These findings suggest that liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells inhibit acute HBV infection; however, the precise mechanism and memory characteristics of these cells require further study. In recent years, &#x3b3;&#x3b4;T cells have attracted more attention for potential use during tumor immunotherapy because of their strong cytotoxic effect on tumor cells, lack of MHC restriction on antigen recognition, and easy expansion both <italic>in vitro</italic> and <italic>in vivo</italic> (<xref ref-type="bibr" rid="B60">60</xref>&#x2013;<xref ref-type="bibr" rid="B62">62</xref>). &#x3b3;&#x3b4;T cells are used for immunotherapy through <italic>in vivo</italic> stimulation with synthetic phosphoantigens like BrHPP, aminodicarbonates such as zoledronate, and glycolipid antigens presented by CD1d or adoptive transfer after expansion <italic>ex vivo</italic> (<xref ref-type="bibr" rid="B63">63</xref>&#x2013;<xref ref-type="bibr" rid="B65">65</xref>). Current research is focused on combining direct antiviral agents and immunotherapy to treat HBV infection. Targeting the host immune system to strengthen innate and specific adaptive immune responses may help to eliminate this virus. DC vaccines, cytokine-induced killer (CIK) cells, immune checkpoint inhibitors, and genetically edited T cells (CAR/TCR-T) are used in the treatment of chronic viral infections and related cancers (<xref ref-type="bibr" rid="B66">66</xref>&#x2013;<xref ref-type="bibr" rid="B68">68</xref>). In view of the antiviral effect of liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells, stimulation of these cells <italic>in vivo</italic> or adoptive transfer of liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells after <italic>ex vivo</italic> expansion may be a new therapeutic strategy for acute HBV infection.</p>
<p>Similar to mice, human livers also contain a liver-resident CD27<sup>lo</sup>CD45RA<sup>lo</sup> subset of V&#x3b4;1<sup>+</sup> &#x3b3;&#x3b4;T cells expressing high levels of CXCR3 and CXCR6. They produce significantly more of the pro-inflammatory cytokines, IFN-&#x3b3; and TNF-&#x3b1;, and may be involved in responding to CMV infection (<xref ref-type="bibr" rid="B69">69</xref>). It is also worth noting that serum HBsAg, HBeAg, and HBV DNA levels are significantly lower in TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice than WT mice (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6F</bold>
</xref>). This may be related to the heterogeneity of &#x3b3;&#x3b4;T cells. &#x3b3;&#x3b4;T cells are a heterogeneous population and consist of different subsets including IFN-&#x3b3;-producing &#x3b3;&#x3b4; T cells, IL-17-producing &#x3b3;&#x3b4; T cells, &#x3b3;&#x3b4; NKT cells, and so on (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B70">70</xref>). The TCR&#x3b4;<sup>&#x2212;/&#x2212;</sup> mice were systemic TCR&#x3b4; gene deletion, and all &#x3b3;&#x3b4;T-cell subsets are deficient. Other &#x3b3;&#x3b4;T-cell subsets in liver may have different, even opposite, effects during acute HBV infection. The roles of other subsets of &#x3b3;&#x3b4;T cells in acute HBV infection deserved further research.</p>
<p>In summary, the current study was the first to demonstrate that CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells are a liver-resident &#x3b3;&#x3b4;T-cell subset with a unique phenotype and tissue-resident characteristics. LSECs mediated the retention of CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells through the interaction between the chemokine receptor, CXCR3, and its ligands, CXCL9 and CXCL11, as well as CXCR6 and its ligand, CXCL16. Liver-resident CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells were protective against acute HBV infection. While additional research is required to better define the exact mechanism by which CXCR3<sup>+</sup>CXCR6<sup>+</sup> &#x3b3;&#x3b4;T cells exert their protective role, findings from the current study provide more insight into liver-resident lymphocytes and provide novel strategies for the treatment of diverse liver diseases.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Committee on the Ethics of Animal Experiments of Shandong University.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author Contributions</title>
<p>YW performed the experiments, analyzed the data, and wrote the manuscript. YG performed and designed the experiments and analyzed the data. YH and YL performed the experiments and analyzed the data. NL provided guidance for the experiment design and contributed to analyzing and discussing the data. CZ directed the research program, provided guidance and suggestions for the experimental design, analyzed the data, and wrote the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by grants from the National Natural Science Foundation of China (91842305, 81771686), the Shandong Provincial Natural Science Foundation (ZR2020MH260), and the Shandong Provincial Key Research and Development Program (Major Scientific and Technological Innovation Project) (2019JZZY021013).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Translational Medicine Core Facility of Advanced Medical Research Institute, Shandong University for consultation and instrument availability that supported this work.</p>
</ack>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2021.757379/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2021.757379/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kubes</surname> <given-names>P</given-names>
</name>
<name>
<surname>Jenne</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Immune Responses in the Liver</article-title>. <source>Annu Rev Immunol</source> (<year>2018</year>) <volume>36</volume>:<page-range>247&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-051116-052415</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>B</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>WI</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Liver: An Organ With Predominant Innate Immunity</article-title>. <source>Hepatology</source> (<year>2008</year>) <volume>47</volume>(<issue>2</issue>):<page-range>729&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/hep.22034</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>From Basic Liver Immunology to Therapeutic Opportunities for Liver Diseases</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>3</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-00607-2</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Innate Lymphocytes: Pathogenesis and Therapeutic Targets of Liver Diseases and Cancer</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>1</issue>):<fpage>57</fpage>&#x2013;<lpage>72</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-00561-z</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruf</surname> <given-names>B</given-names>
</name>
<name>
<surname>Heinrich</surname> <given-names>B</given-names>
</name>
<name>
<surname>Greten</surname> <given-names>TF</given-names>
</name>
</person-group>. <article-title>Immunobiology and Immunotherapy of HCC: Spotlight on Innate and Innate-Like Immune Cells</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>1</issue>):<page-range>112&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-00572-w</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Rudensky</surname> <given-names>AY</given-names>
</name>
</person-group>. <article-title>Hallmarks of Tissue-Resident Lymphocytes</article-title>. <source>Cell</source> (<year>2016</year>) <volume>164</volume>(<issue>6</issue>):<page-range>1198&#x2013;211</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2016.02.048</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brownlie</surname> <given-names>D</given-names>
</name>
<name>
<surname>Scharenberg</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mold</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Hard</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kekalainen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Buggert</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Expansions of Adaptive-Like NK Cells With a Tissue-Resident Phenotype in Human Lung and Blood</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2021</year>) <volume>118</volume>(<issue>11</issue>):<fpage>e2016580118</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2016580118</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Tissue-Resident Lymphocytes: From Adaptive to Innate Immunity</article-title>. <source>Cell Mol Immunol</source> (<year>2019</year>) <volume>16</volume>(<issue>3</issue>):<page-range>205&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-018-0192-y</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>JL</given-names>
</name>
<etal/>
</person-group>. <article-title>The SKI Proto-Oncogene Restrains the Resident CD103(+)CD8(+) T Cell Response in Viral Clearance</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>10</issue>):<page-range>2410&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-0495-7</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>The Roles of Liver-Resident Lymphocytes in Liver Diseases</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1582</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01582</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Horng</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Siao</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Chyuan</surname> <given-names>IT</given-names>
</name>
<name>
<surname>Tsai</surname> <given-names>HF</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>PJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Asialo GM1-Positive Liver-Resident CD8 T Cells That Express CD44 and LFA-1 are Essential for Immune Clearance of Hepatitis B Virus</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>7</issue>):<page-range>1772&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-0376-0</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sojka</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Liver-Resident NK Cells Confer Adaptive Immunity in Skin-Contact Inflammation</article-title>. <source>J Clin Invest</source> (<year>2013</year>) <volume>123</volume>(<issue>4</issue>):<page-range>1444&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI66381</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Ruiz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>WY</given-names>
</name>
<name>
<surname>Holz</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>JZ</given-names>
</name>
<name>
<surname>Zaid</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>YC</given-names>
</name>
<etal/>
</person-group>. <article-title>Liver-Resident Memory CD8(+) T Cells Form a Front-Line Defense Against Malaria Liver-Stage Infection</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>45</volume>(<issue>4</issue>):<fpage>889</fpage>&#x2013;<lpage>902</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.08.011</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swadling</surname> <given-names>L</given-names>
</name>
<name>
<surname>Pallett</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Maini</surname> <given-names>MK</given-names>
</name>
</person-group>. <article-title>Liver-Resident CD8+ T Cells: Learning Lessons From the Local Experts</article-title>. <source>J Hepatol</source> (<year>2020</year>) <volume>72</volume>(<issue>6</issue>):<page-range>1049&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhep.2020.02.001</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Tissue-Resident Natural Killer Cells in the Livers</article-title>. <source>Sci China Life Sci</source> (<year>2016</year>) <volume>59</volume>(<issue>12</issue>):<page-range>1218&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11427-016-0334-2</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayday</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Gammadelta T Cell Update: Adaptate Orchestrators of Immune Surveillance</article-title>. <source>J Immunol</source> (<year>2019</year>) <volume>203</volume>(<issue>2</issue>):<page-range>311&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1800934</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chien</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Meyer</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bonneville</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Gammadelta T Cells: First Line of Defense and Beyond</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<page-range>121&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120216</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Ling</surname> <given-names>N</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Increase in Liver Gammadelta T Cells With Concurrent Augmentation of IFN-Beta Production During the Early Stages of a Mouse Model of Acute Experimental Hepatitis B Virus Infection</article-title>. <source>Exp Ther Med</source> (<year>2020</year>) <volume>19</volume>(<issue>1</issue>):<fpage>67</fpage>&#x2013;<lpage>78</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/etm.2019.8197</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Lung-Resident Gammadelta T Cells and Their Roles in Lung Diseases</article-title>. <source>Immunology</source> (<year>2017</year>) <volume>151</volume>(<issue>4</issue>):<page-range>375&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imm.12764</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodward Davis</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Bergsbaken</surname> <given-names>T</given-names>
</name>
<name>
<surname>Delaney</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Bevan</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Dermal-Resident Versus Recruited Gammadelta T Cell Response to Cutaneous Vaccinia Virus Infection</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>(<issue>5</issue>):<page-range>2260&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1402438</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romagnoli</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Sheridan</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Pham</surname> <given-names>QM</given-names>
</name>
<name>
<surname>Lefrancois</surname> <given-names>L</given-names>
</name>
<name>
<surname>Khanna</surname> <given-names>KM</given-names>
</name>
</person-group>. <article-title>IL-17A-Producing Resident Memory Gammadelta T Cells Orchestrate the Innate Immune Response to Secondary Oral Listeria Monocytogenes Infection</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2016</year>) <volume>113</volume>(<issue>30</issue>):<page-range>8502&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1600713113</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nielsen</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Witherden</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Havran</surname> <given-names>WL</given-names>
</name>
</person-group>. <article-title>Gammadelta T Cells in Homeostasis and Host Defence of Epithelial Barrier Tissues</article-title>. <source>Nat Rev Immunol</source> (<year>2017</year>) <volume>17</volume>(<issue>12</issue>):<page-range>733&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri.2017.101</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lian</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>The Microbiota Maintain Homeostasis of Liver-Resident gammadeltaT-17 Cells in a Lipid Antigen/CD1d-Dependent Manner</article-title>. <source>Nat Commun</source> (<year>2017</year>) <volume>7</volume>:<elocation-id>13839</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms13839</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>196</volume>(<issue>10</issue>):<page-range>4122&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1500846</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamran</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sereti</surname> <given-names>KI</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Weissman</surname> <given-names>IL</given-names>
</name>
<name>
<surname>Ardehali</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Parabiosis in Mice: A Detailed Protocol</article-title>. <source>J Vis Exp</source> (<year>2013</year>) <volume>(80)</volume>:<fpage>50556</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/50556</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Small Intestinal Intraepithelial Lymphocytes Expressing CD8 and T Cell Receptor Gammadelta are Involved in Bacterial Clearance During Salmonella Enterica Serovar Typhimurium Infection</article-title>. <source>Infect Immun</source> (<year>2012</year>) <volume>80</volume>(<issue>2</issue>):<page-range>565&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.05078-11</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zuo</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>TLR9 Regulates the NF-kappaB-NLRP3-IL-1beta Pathway Negatively in Salmonella-Induced NKG2D-Mediated Intestinal Inflammation</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>199</volume>(<issue>2</issue>):<page-range>761&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1601416</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Losurdo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Piscitelli</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ierardi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Di Leo</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Intraepithelial Lymphocytes: Bystanders or Causative Factors in Functional Gastrointestinal Disorders</article-title>? <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>7</issue>):<page-range>1620&#x2013;1</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-00614-3</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kabelitz</surname> <given-names>D</given-names>
</name>
<name>
<surname>Serrano</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kouakanou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kalyan</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Cancer Immunotherapy With Gammadelta T Cells: Many Paths Ahead of Us</article-title>. <source>Cell Mol Immunol</source> (<year>2020</year>) <volume>17</volume>(<issue>9</issue>):<page-range>925&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-0504-x</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribot</surname> <given-names>JC</given-names>
</name>
<name>
<surname>deBarros</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Neves</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Peperzak</surname> <given-names>V</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>CD27 is a Thymic Determinant of the Balance Between Interferon-Gamma- and Interleukin 17-Producing Gammadelta T Cell Subsets</article-title>. <source>Nat Immunol</source> (<year>2009</year>) <volume>10</volume>(<issue>4</issue>):<page-range>427&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1717</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shibata</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yamada</surname> <given-names>H</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Itsumi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yoshikai</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Identification of CD25+ Gamma Delta T Cells as Fetal Thymus-Derived Naturally Occurring IL-17 Producers</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>(<issue>9</issue>):<page-range>5940&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.181.9.5940</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tramonti</surname> <given-names>D</given-names>
</name>
<name>
<surname>Rhodes</surname> <given-names>K</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>N</given-names>
</name>
<name>
<surname>Dalton</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Andrew</surname> <given-names>E</given-names>
</name>
<name>
<surname>Carding</surname> <given-names>SR</given-names>
</name>
</person-group>. <article-title>gammadeltaT Cell-Mediated Regulation of Chemokine Producing Macrophages During Listeria Monocytogenes Infection-Induced Inflammation</article-title>. <source>J Pathol</source> (<year>2008</year>) <volume>216</volume>(<issue>2</issue>):<page-range>262&#x2013;70</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.2412</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xiang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>T</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Human Vgamma9Vdelta2-T Cells Efficiently Kill Influenza Virus-Infected Lung Alveolar Epithelial Cells</article-title>. <source>Cell Mol Immunol</source> (<year>2013</year>) <volume>10</volume>(<issue>2</issue>):<page-range>159&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cmi.2012.70</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackay</surname> <given-names>LK</given-names>
</name>
<name>
<surname>Kallies</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Transcriptional Regulation of Tissue-Resident Lymphocytes</article-title>. <source>Trends Immunol</source> (<year>2017</year>) <volume>38</volume>(<issue>2</issue>):<fpage>94</fpage>&#x2013;<lpage>103</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.it.2016.11.004</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Scanlon</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Griewank</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Constantinides</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Savage</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Barr</surname> <given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>PLZF Induces an Intravascular Surveillance Program Mediated by Long-Lived LFA-1-ICAM-1 Interactions</article-title>. <source>J Exp Med</source> (<year>2011</year>) <volume>208</volume>(<issue>6</issue>):<page-range>1179&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.20102630</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carding</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Egan</surname> <given-names>PJ</given-names>
</name>
</person-group>. <article-title>Gammadelta T Cells: Functional Plasticity and Heterogeneity</article-title>. <source>Nat Rev Immunol</source> (<year>2002</year>) <volume>2</volume>(<issue>5</issue>):<page-range>336&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri797</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nonaka</surname> <given-names>S</given-names>
</name>
<name>
<surname>Naito</surname> <given-names>T</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yamamoto</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moro</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kiyono</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Intestinal Gamma Delta T Cells Develop in Mice Lacking Thymus, All Lymph Nodes, Peyer&#x2019;s Patches, and Isolated Lymphoid Follicles</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>(<issue>4</issue>):<page-range>1906&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.174.4.1906</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shetty</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lalor</surname> <given-names>PF</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>DH</given-names>
</name>
</person-group>. <article-title>Liver Sinusoidal Endothelial Cells - Gatekeepers of Hepatic Immunity</article-title>. <source>Nat Rev Gastroenterol Hepatol</source> (<year>2018</year>) <volume>15</volume>(<issue>9</issue>):<page-range>555&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41575-018-0020-y</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>X</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Broering</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>HBeAg Induces Liver Sinusoidal Endothelial Cell Activation to Promote Intrahepatic CD8 T Cell Immunity and HBV Clearance</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>11</issue>):<page-range>2572&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-021-00769-7</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dudek</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pfister</surname> <given-names>D</given-names>
</name>
<name>
<surname>Donakonda</surname> <given-names>S</given-names>
</name>
<name>
<surname>Filpe</surname> <given-names>P</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>A</given-names>
</name>
<name>
<surname>Laschinger</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Auto-Aggressive CXCR6(+) CD8 T Cells Cause Liver Immune Pathology in NASH</article-title>. <source>Nature</source> (<year>2021</year>) <volume>592</volume>(<issue>7854</issue>):<page-range>444&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586-021-03233-8</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holz</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Chua</surname> <given-names>YC</given-names>
</name>
<name>
<surname>de Menezes</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Draper</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Compton</surname> <given-names>BJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycolipid-Peptide Vaccination Induces Liver-Resident Memory CD8(+) T Cells That Protect Against Rodent Malaria</article-title>. <source>Sci Immunol</source> (<year>2020</year>) <volume>5</volume>(<issue>48</issue>):<fpage>eaaz8035</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciimmunol.aaz8035</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harmon</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jameson</surname> <given-names>G</given-names>
</name>
<name>
<surname>Almuaili</surname> <given-names>D</given-names>
</name>
<name>
<surname>Houlihan</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Hoti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Geoghegan</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Liver-Derived TGF-Beta Maintains the Eomes(hi)Tbet(lo) Phenotype of Liver Resident Natural Killer Cells</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>1502</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01502</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marra</surname> <given-names>F</given-names>
</name>
<name>
<surname>Tacke</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Roles for Chemokines in Liver Disease</article-title>. <source>Gastroenterology</source> (<year>2014</year>) <volume>147</volume>(<issue>3</issue>):<fpage>577</fpage>&#x2013;<lpage>94 e1</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2014.06.043</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yano</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ohira</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nakano</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tanaka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ohdan</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Hepatectomy Leads to Loss of TRAIL-Expressing Liver NK Cells <italic>via</italic> Downregulation of the CXCL9-CXCR3 Axis in Mice</article-title>. <source>PloS One</source> (<year>2017</year>) <volume>12</volume>(<issue>10</issue>):<fpage>e0186997</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0186997</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geissmann</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cameron</surname> <given-names>TO</given-names>
</name>
<name>
<surname>Sidobre</surname> <given-names>S</given-names>
</name>
<name>
<surname>Manlongat</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kronenberg</surname> <given-names>M</given-names>
</name>
<name>
<surname>Briskin</surname> <given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids</article-title>. <source>PloS Biol</source> (<year>2005</year>) <volume>3</volume>(<issue>4</issue>):<fpage>e113</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pbio.0030113</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>X</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Single-Cell RNA Sequencing Reveals the Heterogeneity of Liver-Resident Immune Cells in Human</article-title>. <source>Cell Discovery</source> (<year>2020</year>) <volume>6</volume>(<issue>1</issue>):<fpage>22</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41421-020-0157-z</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hudspeth</surname> <given-names>K</given-names>
</name>
<name>
<surname>Donadon</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cimino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pontarini</surname> <given-names>E</given-names>
</name>
<name>
<surname>Tentorio</surname> <given-names>P</given-names>
</name>
<name>
<surname>Preti</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Human Liver-Resident CD56(bright)/CD16(neg) NK Cells are Retained Within Hepatic Sinusoids <italic>via</italic> the Engagement of CCR5 and CXCR6 Pathways</article-title>. <source>J Autoimmun</source> (<year>2016</year>) <volume>66</volume>:<fpage>40</fpage>&#x2013;<lpage>50</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jaut.2015.08.011</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hess</surname> <given-names>LU</given-names>
</name>
<name>
<surname>Martrus</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ziegler</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Langeneckert</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Salzberger</surname> <given-names>W</given-names>
</name>
<name>
<surname>Goebels</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>The Transcription Factor Promyelocytic Leukemia Zinc Finger Protein Is Associated With Expression of Liver-Homing Receptors on Human Blood CD56(bright) Natural Killer Cells</article-title>. <source>Hepatol Commun</source> (<year>2020</year>) <volume>4</volume>(<issue>3</issue>):<page-range>409&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/hep4.1463</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laky</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lefrancois</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lingenheld</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Ishikawa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lewis</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Olson</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Enterocyte Expression of Interleukin 7 Induces Development of Gammadelta T Cells and Peyer&#x2019;s Patches</article-title>. <source>J Exp Med</source> (<year>2000</year>) <volume>191</volume>(<issue>9</issue>):<page-range>1569&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.191.9.1569</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oida</surname> <given-names>T</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nanno</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kanamori</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Saito</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kubota</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of Gut Cryptopatches in Early Extrathymic Maturation of Intestinal Intraepithelial T Cells</article-title>. <source>J Immunol</source> (<year>2000</year>) <volume>164</volume>(<issue>7</issue>):<page-range>3616&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.164.7.3616</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotton</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Fabian</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Mulligan</surname> <given-names>RC</given-names>
</name>
</person-group>. <article-title>A Novel Stem-Cell Population in Adult Liver With Potent Hematopoietic-Reconstitution Activity</article-title>. <source>Blood</source> (<year>2005</year>) <volume>106</volume>(<issue>5</issue>):<page-range>1574&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2005-03-1017</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crane</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Jeffery</surname> <given-names>E</given-names>
</name>
<name>
<surname>Morrison</surname> <given-names>SJ</given-names>
</name>
</person-group>. <article-title>Adult Haematopoietic Stem Cell Niches</article-title>. <source>Nat Rev Immunol</source> (<year>2017</year>) <volume>17</volume>(<issue>9</issue>):<page-range>573&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri.2017.53</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Lo</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>ZF</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>YX</given-names>
</name>
<etal/>
</person-group>. <article-title>Hematopoietic Chimerism in Liver Transplantation Patients and Hematopoietic Stem/Progenitor Cells in Adult Human Liver</article-title>. <source>Hepatology</source> (<year>2012</year>) <volume>56</volume>(<issue>4</issue>):<page-range>1557&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/hep.25820</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname> <given-names>D</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Kupffer Cells Promote the Differentiation of Adult Liver Hematopoietic Stem and Progenitor Cells Into Lymphocytes <italic>via</italic> ICAM-1 and LFA-1 Interaction</article-title>. <source>Stem Cells Int</source> (<year>2019</year>) <volume>2019</volume>:<elocation-id>4848279</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/4848279</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Interferon Gamma Inhibits the Differentiation of Mouse Adult Liver and Bone Marrow Hematopoietic Stem Cells by Inhibiting the Activation of Notch Signaling</article-title>. <source>Stem Cell Res Ther</source> (<year>2019</year>) <volume>10</volume>(<issue>1</issue>):<fpage>210</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13287-019-1311-0</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname> <given-names>L</given-names>
</name>
<name>
<surname>Vienne</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kerdiles</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Etiennot</surname> <given-names>M</given-names>
</name>
<name>
<surname>Escaliere</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Liver Type 1 Innate Lymphoid Cells Develop Locally <italic>via</italic> an Interferon-Gamma-Dependent Loop</article-title>. <source>Science</source> (<year>2021</year>) <volume>371</volume>(<issue>6536</issue>):<fpage>eaba4177</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aba4177</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Single-Cell Analysis Reveals the Origins and Intrahepatic Development of Liver-Resident IFN-Gamma-Producing Gammadelta T Cells</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>4</issue>):<page-range>954&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-021-00656-1</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khairallah</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Sheridan</surname> <given-names>BS</given-names>
</name>
</person-group>. <article-title>Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells</article-title>. <source>Front Immunol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>2636</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.02636</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Traum</surname> <given-names>D</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ojiro</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>DK</given-names>
</name>
<etal/>
</person-group>. <article-title>Distinct Phenotype and Function of Circulating Vdelta1+ and Vdelta2+ gammadeltaT-Cells in Acute and Chronic Hepatitis B</article-title>. <source>PloS Pathog</source> (<year>2019</year>) <volume>15</volume>(<issue>4</issue>):<fpage>e1007715</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1007715</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebestyen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Prinz</surname> <given-names>I</given-names>
</name>
<name>
<surname>Dechanet-Merville</surname> <given-names>J</given-names>
</name>
<name>
<surname>Silva-Santos</surname> <given-names>B</given-names>
</name>
<name>
<surname>Kuball</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Translating Gammadelta (Gammadelta) T Cells and Their Receptors Into Cancer Cell Therapies</article-title>. <source>Nat Rev Drug Discovery</source> (<year>2020</year>) <volume>19</volume>(<issue>3</issue>):<page-range>169&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41573-019-0038-z</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>The Role of Human Gammadelta T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy</article-title>. <source>Cells</source> (<year>2020</year>) <volume>9</volume>(<issue>5</issue>):<fpage>1206</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells9051206</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>G</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>CFTR is a Negative Regulator of Gammadelta T Cell IFN-Gamma Production and Antitumor Immunity</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>8</issue>):<page-range>1934&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-0499-3</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo Presti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pizzolato</surname> <given-names>G</given-names>
</name>
<name>
<surname>Gulotta</surname> <given-names>E</given-names>
</name>
<name>
<surname>Cocorullo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Gulotta</surname> <given-names>G</given-names>
</name>
<name>
<surname>Dieli</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Current Advances in Gammadelta T Cell-Based Tumor Immunotherapy</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>1401</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.01401</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wada</surname> <given-names>I</given-names>
</name>
<name>
<surname>Matsushita</surname> <given-names>H</given-names>
</name>
<name>
<surname>Noji</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mori</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yamashita</surname> <given-names>H</given-names>
</name>
<name>
<surname>Nomura</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Intraperitoneal Injection of <italic>In Vitro</italic> Expanded Vgamma9Vdelta2 T Cells Together With Zoledronate for the Treatment of Malignant Ascites Due to Gastric Cancer</article-title>. <source>Cancer Med</source> (<year>2014</year>) <volume>3</volume>(<issue>2</issue>):<page-range>362&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cam4.196</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xiang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Alnaggar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kouakanou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>He</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Allogeneic Vgamma9Vdelta2 T-Cell Immunotherapy Exhibits Promising Clinical Safety and Prolongs the Survival of Patients With Late-Stage Lung or Liver Cancer</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>2</issue>):<page-range>427&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-020-0515-7</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gehring</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Protzer</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>Targeting Innate and Adaptive Immune Responses to&#xa0;Cure Chronic HBV Infection</article-title>. <source>Gastroenterology</source> (<year>2019</year>) <volume>156</volume>(<issue>2</issue>):<page-range>325&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.gastro.2018.10.032</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>3127</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.03127</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Chimeric Antigen Receptor- and Natural Killer Cell Receptor-Engineered Innate Killer Cells in Cancer Immunotherapy</article-title>. <source>Cell Mol Immunol</source> (<year>2021</year>) <volume>18</volume>(<issue>9</issue>):<page-range>2083&#x2013;100</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423-021-00732-6</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunter</surname> <given-names>S</given-names>
</name>
<name>
<surname>Willcox</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Davey</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Kasatskaya</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Jeffery</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Chudakov</surname> <given-names>DM</given-names>
</name>
<etal/>
</person-group>. <article-title>Human Liver Infiltrating Gammadelta T Cells are Composed of Clonally Expanded Circulating and Tissue-Resident Populations</article-title>. <source>J Hepatol</source> (<year>2018</year>) <volume>69</volume>(<issue>3</issue>):<page-range>654&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jhep.2018.05.007</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paul</surname> <given-names>S</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Shilpi, Lal</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Phenotypic and Functional Plasticity of Gamma-Delta (Gammadelta) T Cells in Inflammation and Tolerance</article-title>. <source>Int Rev Immunol</source> (<year>2014</year>) <volume>33</volume>(<issue>6</issue>):<page-range>537&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/08830185.2013.863306</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>